CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $6.08 million. The enterprise value is $3.25 million.
Important Dates
The next estimated earnings date is Wednesday, May 27, 2026, before market open.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLGN has 14.42 million shares outstanding. The number of shares has increased by 6.54% in one year.
| Current Share Class | 14.42M |
| Shares Outstanding | 14.42M |
| Shares Change (YoY) | +6.54% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 28.48% |
| Owned by Institutions (%) | 10.95% |
| Float | 10.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.53 |
| Forward PS | 0.74 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.53 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -117.56% and return on invested capital (ROIC) is -56.35%.
| Return on Equity (ROE) | -117.56% |
| Return on Assets (ROA) | -48.67% |
| Return on Invested Capital (ROIC) | -56.35% |
| Return on Capital Employed (ROCE) | -141.54% |
| Weighted Average Cost of Capital (WACC) | 6.38% |
| Revenue Per Employee | $60,795 |
| Profits Per Employee | -$294,590 |
| Employee Count | 39 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.03% in the last 52 weeks. The beta is 0.94, so CLGN's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -81.03% |
| 50-Day Moving Average | 0.53 |
| 200-Day Moving Average | 1.71 |
| Relative Strength Index (RSI) | 44.93 |
| Average Volume (20 Days) | 152,205 |
Short Selling Information
The latest short interest is 65,694, so 0.59% of the outstanding shares have been sold short.
| Short Interest | 65,694 |
| Short Previous Month | 62,082 |
| Short % of Shares Out | 0.59% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.86 |
Income Statement
In the last 12 months, CLGN had revenue of $2.37 million and -$11.49 million in losses. Loss per share was -$0.94.
| Revenue | 2.37M |
| Gross Profit | 1.54M |
| Operating Income | -11.48M |
| Pretax Income | -11.49M |
| Net Income | -11.49M |
| EBITDA | -10.57M |
| EBIT | -11.48M |
| Loss Per Share | -$0.94 |
Full Income StatementBalance Sheet
The company has $5.59 million in cash and $2.85 million in debt, with a net cash position of $2.75 million or $0.19 per share.
| Cash & Cash Equivalents | 5.59M |
| Total Debt | 2.85M |
| Net Cash | 2.75M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 6.08M |
| Book Value Per Share | 0.47 |
| Working Capital | 4.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.42 million and capital expenditures -$28,000, giving a free cash flow of -$9.45 million.
| Operating Cash Flow | -9.42M |
| Capital Expenditures | -28,000 |
| Depreciation & Amortization | 912,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -9.45M |
| FCF Per Share | -$0.66 |
Full Cash Flow StatementMargins
| Gross Margin | 64.78% |
| Operating Margin | -484.31% |
| Pretax Margin | -484.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.54% |
| Shareholder Yield | -6.54% |
| Earnings Yield | -191.59% |
| FCF Yield | -157.54% |
Analyst Forecast
The average price target for CLGN is $11.00, which is 2,507.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.00 |
| Price Target Difference | 2,507.87% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 1:1.5.
| Last Split Date | Nov 21, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:1.5 |
Scores
CLGN has an Altman Z-Score of -15.23 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.23 |
| Piotroski F-Score | 3 |
